FDA NDC Directory · JSON-LD · Markdown

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

NDC 43975-281 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerANI Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205401
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE DL-ASPARTATE MONOHYDRATE (6.25 mg/1)
AMPHETAMINE SULFATE (6.25 mg/1)
DEXTROAMPHETAMINE SACCHARATE (6.25 mg/1)
DEXTROAMPHETAMINE SULFATE (6.25 mg/1)
Marketing started20200316
Package count1

External sources

Source: openFDA. Public-domain (CC0).